Welcome to the website for Charité – Universitätsmedizin Berlin, a joint institution of Freie Universität Berlin and Humboldt-Universität zu Berlin.
To navigate directly to a specific page or section, please use the 'Go To' commands as follows:
You are here:
- ENABLE: Enabling MYC family protein druggability, fundig: since 2018
- A CAR- T cell approch for solid tumor attack using neuroblastoma as a model (CASTAN), funding since 2018
- Evaluation of CAR-T cell therapy for retinoblastoma, since 2017
- Developing an off-the-shelf cell product for tumor-specific enhancement of inflammation and checkpoint inhibitor responsiveness; in cooperation with PD Dr. Sebastian Ochsenreither, since 2018
Personal funding and stipends
The copyright of the logos lies with the respective institution.